Market by Drug Class, Application, and Country | Forecast 2019-2028
The Asia-Pacific dermatological therapeutics market is expected to make progress at a CAGR of 8.32% in terms of revenue throughout the estimated period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries assessed
in this region include:
• China
• Japan
• India
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC countries
2019’s World Population Aging report estimates the
elderly population of China, aged 65 years and above, to rise steeply over the
coming years. In 2019, there were 164.48 million people in this age group, and
this number is expected to rise to 246.98 million people by 2030. Older adults
are more likely to be affected with dermatological conditions. And this is
expected to raise the demand for dermatological therapeutics in the country. Moreover,
other factors, such as changes in lifestyle, improvement in healthcare
infrastructure, and increased public awareness regarding health risks, are
leading the Chinese dermatological therapeutics market on a growth path.
Even in Japan, the geriatric population, comprising people aged 65 years
and above, is continually rising. In its 2015 World
Population Prospects report, the United
Nations had estimated this population to amount to 35.9 million people
in 2020. It must also be noted that, people in Japan are aging faster than
people in any other country. The elderly require dermatological services
frequently, as they are highly prone to skin-related disorders. They form a
large section of the customer base for dermatological procedures, which has
increased the demand for dermatological
therapeutics. This increased demand is fueling the growth of the studied market
in Japan over the projected period.
Galderma provides science-based solutions for skin health. The company operates through three business units: Prescription, Aesthetics, and Consumer care. Its product portfolio includes a range of leading medical and consumer skin health brands, for conditions such as rosacea, acne, atopic dermatitis, psoriasis, sun protection, skin aging, and skin cancer. Galderma has a significant presence in the Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORTTABLE OF CONTENTS
1. ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. ASIA-PACIFIC
IS MOST ENCOURAGING REGIONAL MARKET
2.2.2. CHINA
IS LEADING OVERALL MARKET
2.2.3. ADVANCEMENTS
IN BIOLOGICS
2.2.4. ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1. INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. GRAVE
SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1. UNAWARENESS REGARDING
DERMATOLOGICAL DIAGNOSIS
3. ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. ASIA-PACIFIC
5.1.1. CHINA
5.1.2. JAPAN
5.1.3. INDIA
5.1.4. SOUTH
KOREA
5.1.5. ASEAN
COUNTRIES
5.1.6. AUSTRALIA
& NEW ZEALAND
5.1.7. REST
OF ASIA-PACIFIC
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET
ATTRACTIVENESS INDEX
TABLE 3: VENDOR
SCORECARD
TABLE 4: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 5: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 6: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
FIGURE 1: PORTER’S FIVE
FORCE ANALYSIS
FIGURE 2: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $
BILLION)
FIGURE 3: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $
BILLION)
FIGURE 4: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 5: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $
BILLION)
FIGURE 6: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 7: ASIA-PACIFIC DERMATOLOGICAL
THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)
FIGURE 8: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 9: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 10: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)
FIGURE 11: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)
FIGURE 12: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $
BILLION)
FIGURE 13: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)
FIGURE 14: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $
BILLION)
FIGURE 15: ASIA-PACIFIC
DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 16: CHINA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: JAPAN
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 18: INDIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 19: SOUTH KOREA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 20: ASEAN
COUNTRIES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 21: AUSTRALIA
& NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 22: REST OF ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)